Production of protein array for serum antibody screening

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3P30CA060553-25S5

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    1997
    2023
  • Known Financial Commitments (USD)

    $395,000
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Leonidas C Platanias
  • Research Location

    United States of America
  • Lead Research Institution

    Northwestern University At Chicago
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

We propose to purify SARS-CoV-2 proteins to build a plate or filter-based array for rapid assessment of antibody responses. Proteins will be expressed in E. coli and purified as recombinant proteins. The arrays will initially be constructed manually using a vacuum blot system or ELISA plates. If arrays prove useful, a robotic system will be retooled. In addition to proteins already under study, we would expand our library to include all of the smaller open reading frames, especially proteins E and M, which are 100% conserved with SARS. The SARS-CoV-2 proteome can be covered in a 30 protein array. These arrays would then be used to ask novel questions about the development of the immune response in different patient cohorts, including cancer patients.